CRH Investors Logo

CRH Medical Announces Date for Second Quarter 2015 Results and Conference Call

VANCOUVER, B.C. – July 28, 2015 – CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced that it plans to release its financial results for the second quarter ended June 30, 2015, at 8:30 am ET on Thursday, July 30, 2015.

A telephone conference call hosted by management to discuss the financial results will be held on Thursday, July 30, 2015 at 10 am ET.

The telephone numbers for the conference call are (877) 291-4570 or (647) 788-4919.

At the call’s completion, an audio replay will be available by calling (800) 585-8367 or (416) 621-4642 and using passcode 92572263. The phone replay will be available until August 14, 2015.

About CRH Medical Corporation:

CRH Medical Corporation is a North American company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases. The Company’s product distribution strategy focuses on physician education, patient outcomes, and patient awareness. The Company’s first product, the CRH O’Regan System, is a single use, disposable, hemorrhoid banding technology that is safe and highly effective in treating hemorrhoid grades I – IV.  CRH distributes the CRH O’Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians, allowing CRH to create meaningful relationships with the physicians it serves. CRH also operates a full service gastroenterology anesthesia services business, which provides anesthesia services to patients undergoing endoscopies and colonoscopies. Performing these procedures under anesthesia provides a greater degree of comfort to the patient and allows the gastroenterologist to perform more procedures than in the absence of anesthesia. CRH expects to leverage its relationships and the capabilities it has attained through acquisitions in order to consolidate the highly fragmented gastroenterology anesthesia provider business. The Company’s goal is to establish CRH as the premier provider of innovative products and essential services to gastroenterologists throughout the United States. For more information visit our website at


For more information, please contact:
David Matousek, Director Investor Relations
CRH Medical Corporation
604.633.1440 x1030

– Or –

Edward Wright, Chief Executive Officer
CRH Medical Corporation
604.633.1440 x1008